| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115
Received 24 April 2007/ Returned for modification 1 June 2007/ Accepted 9 August 2007
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
In addition to sliding, nucleosome-remodeling complexes can also disassemble histone octamers from DNA. In vitro, such histone eviction is stimulated by histone chaperones, such as Asf1 and Nap1 (32), and acetylated nucleosomes (9). In vivo, histone eviction is mediated by DNA-binding transcriptional activators bound to their target sites in promoter regions (4, 5, 14, 50, 59). Histones are also evicted during the process of transcriptional elongation by RNA polymerase (Pol) II, and such eviction is critical for passage of Pol II through the coding region (27, 30, 53, 59). It is presumed that nucleosome-remodeling complexes directly mediate activator- and elongation-dependent histone eviction in vivo, but the specific complexes that perform these functions have not yet been identified.
Saccharomyces cerevisiae Swi/Snf, the first nucleosome-remodeling complex to be described, contains 11 subunits, each of which is required for Swi/Snf function in vivo (57). The Swi/Snf complex plays a direct role in the mechanism by which DNA-binding activator proteins stimulate transcriptional initiation by Pol II. In vitro, activator proteins directly interact with Swi/Snf (40-42, 47, 61, 62) and drive nucleosome eviction (18). Activator proteins recruit Swi/Snf to activator-binding sites in vivo (12, 15, 60). Upon recruitment, Swi/Snf locally alters nucleosome positioning and perhaps other features of chromatin structure (17, 20, 36), but its effect on nucleosome density has not been determined. Recruitment of Swi/Snf can also facilitate the association of SAGA histone acetylase complexes (12), and conversely, histone acetylation facilitates association of Swi/Snf to nucleosomes (19). When artificially recruited to promoters, Swi/Snf stimulates transcription in a manner that depends on the catalytic activity of the complex (29). Loss of Swi/Snf function reduces activator-dependent recruitment of the basic transcription machinery (12, 31, 37, 49) and hence activator-dependent induction of gene expression in response to appropriate environmental signals.
In addition to its role in transcriptional activation, there is some evidence suggesting the possibility that the Swi/Snf complex may have a role during Pol II elongation. Brg1 and Brm, the catalytic subunits of distinct human Swi/Snf complexes, have been observed in the coding regions of HSP70 and CD44 genes, respectively (2, 11). Yeast cells lacking Swi/Snf are sensitive to drugs that inhibit Pol II elongation. Swi/Snf also exhibits genetic and physical interactions with proteins that can function as Pol II elongation factors, including Asf1, Spt6, Spt16, and TFIIS (13, 33, 38, 43).
In this paper, we show that the Swi/Snf complex travels through coding regions with elongating Pol II. Further, loss of Swi/Snf reduces initiation within coding regions that is observed in FACT-depleted cells, suggesting that Swi/Snf is important for histone eviction during Pol II elongation. We also find that Swi2 is necessary for the activator-dependent histone eviction from the SUC2 promoter that is independent of transcriptional activity.
| MATERIALS AND METHODS |
|---|
|
|
|---|
TATA mutant strains (20) have been previously described. The strains expressing Swi3- and Snf11-18xMyc were made in JDY51, an FT5 strain background, as previously described (15), and verified by Western blotting for the tagged protein. Occupancy of histone H2B was monitored with a strain expressing FLAG-tagged histone H2B (46, 53). The swi2 null mutant was made via one-step gene replacement with a KanMX cassette or URA3 gene and phenotypically tested (significant growth defect and poor growth on galactose). The GAL1-YLR454 strain has been previously described (35), and the GRE2-YLR454 construct has 900 bp of the GRE2 promoter proximal to the YLR454 coding region. GAL1-YLR454 and GRE2-YLR454 strains were constructed via one-step integration. The relevant genotypes of all newly made strains were verified by PCR. Media. All strains were grown in yeast extract-peptone (YP) containing 2% carbon source, except for the GAL1-YLR454 and GRE2-YLR454 strains, which were grown in medium containing 2% carbon source and Casamino Acids. For GRE2 induction experiments, cells were osmotically shocked with 0.4 M NaCl. For the galactose-to-glucose shifts, cells were removed from medium containing 2% galactose by rapid centrifugation and then quickly resuspended in new medium containing 2% glucose. For MET repression, cells were grown overnight in synthetic complete medium lacking methionine (activating conditions) and repressed by the addition of 5 mM methionine. For the heat shock experiments, cells were grown overnight in YP-dextrose (YPD) at 30°C and then heat shocked at 39°C. For SUC2 induction experiments, cells were grown overnight in YPD, washed once in H2O, and resuspended in YP containing 0.05% glucose. For GAL1-YLR454 experiments and experiments with swi2 mutants, cells were grown overnight in media containing 2% galactose and 0.025% glucose. Glucose was then added to a concentration of 4% to repress GAL genes. Plates with nucleotide-depleting drugs are YPD containing 45 µg/ml mycophenolic acid (MPA) or Casamino Acids lacking uracil plus 100 µg/ml 6-azauracil (6-AU). Cells were grown on YPD with or without MPA or Casamino Acids lacking 6-AU for 2 days and grown on Casamino Acids plus 6-AU for 5 days.
Chromatin immunoprecipitation. Chromatin immunoprecipitation was carried out with a modified version of a procedure described previously (28). Cells (A600 of 0.7) were fixed in 1% formaldehyde for 20 min at room temperature, quenched for 5 min with glycine, and lysed with zirconia-silica beads (BioSpec Products) in a mini-bead beater (BioSpec Products). Chromatin was first pelleted by centrifugation and then solubilized by sonication (Branson sonifier 350, two times, 100% duty, power setting of 5, 30 s for each cycle). Cross-linked chromatin was immunoprecipitated with monoclonal antibodies to the Myc epitope (9E10; Upstate), Rbp1 (8WG16; Covance), or FLAG epitope (Sigma anti-FLAG M2) or with polyclonal antibodies to histone H3 (Abcam). Quantitative PCR analyses were performed in real time with an Applied Biosystems 7700 or 7000 sequence detector. Percent immunoprecipitation efficiency was determined by dividing the amount of PCR product in the immunoprecipitated sample by the amount of PCR product in the input sample and corrected for a dilution factor. Relative occupancy values were calculated by dividing the percent immunoprecipitation efficiency of the target DNA by the efficiency of an intergenic region of chromosome I, which was usually defined as 1.0. For all data shown, each experiment was performed independently at least twice.
RNA analysis. DNase I-treated RNA was purified with the RNeasy QIAGEN kit, and cDNA was generated with a poly(dT) primer and Superscript III reverse transcriptase (Invitrogen). Real-time PCR was used to quantify cDNA levels using the level of POL1 RNA as an internal control.
| RESULTS |
|---|
|
|
|---|
|
The Swi/Snf complex travels with elongating Pol II. We addressed whether Swi/Snf travels with elongating Pol II using a modified version of a procedure that kinetically monitors the first wave of Pol II transcription (34, 35, 53, 55). Using a gene in which the large (8-kb) YLR454 coding region is controlled by the osmotically inducible GRE2 promoter (48), we determined the level of Swi2 and Pol II association at various positions within the YLR454 coding region following addition of NaCl. In the YLR454 coding region, the patterns of Swi2 and Pol II occupancy are indistinguishable during the first wave of Pol II transcription (Fig. 2A and B), indicating that Swi/Snf travels with elongating Pol II.
|
|
As expected, activation results in recruitment of Swi2 (Fig. 4A) and decreased H2B and H3 occupancy (Fig. 4B and C) at the SUC2 promoter region. Importantly, there is a significant defect in H2B and H3 eviction in the swi2 mutant strain (Fig. 4B and C). Histone eviction in a strain deleted for the SUC2 TATA region occurs as efficiently as in the wild-type strain (Fig. 4B), indicating that it is independent of transcription and recruitment of general initiation factors and Pol II. Thus, the Swi/Snf complex is necessary for activator-mediated eviction of histones at the SUC2 promoter during induction in vivo.
|
|
The wild-type and swi2 mutant strain behave indistinguishably with respect to the rate of Pol II elongation (Fig. 5B). Specifically, the time difference between the Pol II decay curves near the promoter and 8 kb downstream are comparable in the two strains. Furthermore, the swi2 deletion strain does not show a defect in Pol II processivity (i.e., lower Pol II density at 3' positions compared to 5' positions), which is a consequence of a reduced Pol II elongation rate (34). It should be noted, however, that Pol II dissociation just downstream of the promoter takes about 1 minute longer in the swi2 mutant than in the wild-type strain, and this 1-minute difference persists at more downstream positions in the YLR454 coding region (Fig. 5B). This observation indicates that the glucose shutoff per se is slower in the swi2 mutant strain, either because of its reduced growth rate and/or some indirect effect on carbon source metabolism.
The Swi/Snf complex affects internal initiation and histone density in FACT-depleted cells. As Swi2 exhibits genetic and biochemical interactions with Asf1 and the FACT subunit Spt16 (33, 38), we examined the effects of Swi2 on histone and Pol II occupancy in asf1 and spt16 backgrounds. As shown previously, Spt16 (25, 35) and Asf1 (52) are important for histone deposition after passage of elongating Pol II and as a consequence, for inhibiting internal initiation from cryptic promoters within coding regions. In accord with these observations, spt16 and asf1 mutant strains display higher RNA levels and reduced histone density at the 3' ends of certain genes than observed at the corresponding 5' ends (Fig. 6A). In contrast, the swi2 strain shows equal levels of RNA at the 5' and 3' ends of these genes, indicating that Swi/Snf is not required to inhibit internal initiation. Interestingly, internal initiation due to the spt16 mutation is suppressed by the swi2 mutation (Fig. 6B and C). Furthermore, in comparison to the spt16 single mutant, the swi2 spt16 double mutant exhibits higher levels of histone H3 towards the 3' end of STE11, VPS72, and SPB4 (Fig. 6D). This observation suggests that, in a FACT-depleted strain, Swi2 is important for histone eviction within coding regions.
|
| DISCUSSION |
|---|
|
|
|---|
Here, we demonstrate that the Swi/Snf complex is necessary for eviction of H3 and H2B, and hence nucleosomes, at the SUC2 promoter. Nucleosome eviction requires conditions of transcriptional activation, but not transcription per se, indicating that it is activator dependent. Although the activator(s) that mediates SUC2 induction is not clearly identified, we presume that Swi/Snf has a direct role in nucleosome eviction, because it is rapidly recruited to the SUC2 promoter in response to activating conditions. Last, we suggest that Swi/Snf is involved in nucleosome eviction by other activators that recruit this nucleosome-remodeling complex to enhancers.
As histone chaperones are required for nucleosome eviction in vitro (32) and Asf1 is important for Pho4-dependent eviction in vivo (1), it seems likely that Asf1 (or another histone chaperone) is important for Swi/Snf-dependent eviction of nucleosomes at the SUC2 promoter. There is no evidence that activator proteins interact directly with Asf1 or other histone chaperones. This strongly suggests that such histone chaperones are "recruited" to promoters by recognizing altered histone-DNA structures generated by the Swi/Snf complex and other nucleosome-remodeling activities. Such an indirect recruitment model is analogous to our previous suggestion for how Asf1 is important for histone eviction and deposition during transcriptional elongation by RNA Pol II (52).
In addition to its role in histone eviction, the Swi/Snf complex is necessary for histone deposition at the PHO5 promoter that occurs when cells are transferred to noninducing conditions (51). This seems paradoxical, in that Swi/Snf association with the PHO5 promoter is correlated to activation. Perhaps, the role of Swi/Snf in histone deposition occurs during the transition between inducing and noninducing conditions, when intermediate (and gradually decreasing) levels of Swi/Snf would be predicted to be associated with the PHO5 promoter. Alternatively, the role of Swi/Snf might not be connected to activator-mediated recruitment, but rather to its nonspecific and genome-wide activity.
Evidence that the Swi/Snf complex is a Pol II elongation factor. Pol II elongation is mechanistically linked to posttranscriptional processes, such as 5'-end capping, splicing, 3'-end formation, polyadenylation, and nuclear export. As a consequence, many proteins travel with elongating Pol II throughout mRNA coding regions. Here, we show that in addition to its ability to be recruited to promoter regions by activator proteins, Swi/Snf also travels with elongating Pol II throughout mRNA coding regions. There are two possible mechanisms by which Swi/Snf travels with Pol II. First, Swi/Snf might associate with Pol II, either directly or indirectly by associating with one or more of the many factors that travel with elongating Pol II (e.g., FACT, Paf complex, Spt6, and TREX). In this regard, Swi/Snf has been reported to associate with a Pol II "holoenzyme" (58), although this result is controversial. Alternatively, as proposed for the histone chaperone Asf1 (52), Swi/Snf might recognize distorted chromatin that arises during the process of transcriptional elongation and permits passage of Pol II. In this view, Swi/Snf would dissociate from the mRNA coding region upon passage of Pol II and restoration of normal chromatin structure.
As is the case for many factors that travel with elongating Pol II (34), the Swi/Snf complex does not detectably affect either the Pol II elongation rate or processivity. However, a key feature of Pol II elongation in vivo is the dynamic cycle of nucleosome eviction and deposition that permits passage of Pol II and then restores normal chromatin structure. Proteins that travel with elongating Pol II and affect this dynamic cycle of histone eviction and deposition play a direct role in Pol II elongation and can be considered elongation factors. Thus, Asf1, Spt6, and FACT behave as elongation factors, because loss-of-function mutations cause decreased histone deposition and internal initiation within coding regions in vivo (8, 24, 25). Importantly, we show that Swi/Snf is important for internal initiation observed in cells depleted for the Spt16 subunit of FACT. Furthermore, the spt16 swi2 double mutant exhibits higher H3 occupancy towards the 3' end of genes than the single spt16 mutant does. While we cannot exclude the formal possibility that Swi/Snf inhibits histone deposition, these results suggest that Swi/Snf is important for histone eviction within coding regions in a FACT-depleted background.
Pol II elongation on chromatin templates is virtually blocked by nucleosomes or histone H3/H4 tetramers (10, 22, 23), strongly suggesting that histone eviction is required for transcriptional elongation. As ATP-dependent nucleosome-remodeling complexes (together with histone chaperones) are the major (and perhaps only) biochemical entities capable of histone eviction, it is likely that they are essential for Pol II elongation. Our results provide strong evidence that the Swi/Snf complex plays a role in Pol II elongation via its effects on histone eviction. However, cells lacking Swi/Snf grow (albeit less well than wild-type cells), do not display a defect in Pol II elongation rate, and have only a modest effect on histone density. These observations strongly suggest that histone eviction during Pol II elongation is also mediated by other nucleosome-remodeling complexes (and perhaps other factors). The RSC complex is an attractive candidate in this regard, because it is the only nucleosome-remodeling complex essential for yeast cell growth (7). However, genome-wide analysis did not reveal a relationship between RSC occupancy and Pol II transcription (44), whereas such a relationship was observed in a comparable analysis with Set1 histone methylase (45). The relative contributions of the multiple nucleosome-remodeling complexes to histone eviction during Pol II elongation remain to be determined.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants to K.S. from the National Institutes of Health (GM30186).
| FOOTNOTES |
|---|
Published ahead of print on 20 August 2007. ![]()
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Batsche, E., M. Yaniv, and C. Muchardt. 2006. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat. Struct. Mol. Biol. 13:22-29.[CrossRef][Medline]
3. Becker, P. B., and W. Horz. 2002. ATP-dependent nucleosome remodeling. Annu. Rev. Biochem. 71:247-273.[CrossRef][Medline]
4. Boeger, H., J. Griesenbeck, J. S. Strattan, and R. D. Kornberg. 2003. Nucleosomes unfold completely at a transcriptionally active promoter. Mol. Cell 11:1587-1598.[CrossRef][Medline]
5. Boeger, H., J. Griesenbeck, J. S. Strattan, and R. D. Kornberg. 2004. Removal of promoter nucleosomes by disassembly rather than sliding in vivo. Mol. Cell 14:667-673.[CrossRef][Medline]
6. Cairns, B. R. 2005. Chromatin remodeling complexes: strength in diversity, precision through specialization. Curr. Opin. Genet. Dev. 15:185-190.[CrossRef][Medline]
7. Cairns, B. R., Y. Lorch, Y. Li, M. Zhang, L. Lacomis, H. Erdjument-Bromage, P. Tempst, J. Du, B. Laurent, and R. D. Kornberg. 1996. RSC, an essential, abundant chromatin-remodeling complex. Cell 87:1249-1260.[CrossRef][Medline]
8. Carrozza, M. J., B. Li, L. Florens, T. Suganuma, S. K. Swanson, K. K. Lee, W. J. Shia, S. Anderson, J. Yates, M. P. Washburn, and J. L. Workman. 2005. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123:581-592.[CrossRef][Medline]
9. Chandy, M., J. L. Gutierrez, P. Prochasson, and J. L. Workman. 2006. SWI/SNF displaces SAGA-acetylated nucleosomes. Eukaryot. Cell 5:1738-1747.
10. Chang, C. H., and D. S. Luse. 1997. The H3/H4 tetramer blocks transcript elongation by RNA polymerase II in vitro. J. Biol. Chem. 272:23427-23434.
11. Corey, L. L., C. S. Weirich, I. J. Benjamin, and R. E. Kingston. 2003. Localized recruitment of a chromatin-remodeling activity by an activator in vivo drives transcriptional elongation. Genes Dev. 17:1392-1401.
12. Cosma, M. P., T. Tanaka, and K. Nasmyth. 1999. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 97:299-311.[CrossRef][Medline]
13. Davie, J. K., and C. M. Kane. 2000. Genetic interactions between TFIIS and the Swi/Snf chromatin remodeling complex. Mol. Cell. Biol. 20:5960-5973.
14. Deckert, J., and K. Struhl. 2001. Histone acetylation at promoters is differentially affected by activators and repressors. Mol. Cell. Biol. 21:2726-2735.
15. Deckert, J., and K. Struhl. 2002. Targeted recruitment of Rpd3 histone deacetylase represses transcription by inhibiting recruitment of Swi/Snf, SAGA, and TATA binding protein. Mol. Cell. Biol. 22:6458-6470.
16. Desmoucelles, C., B. Pinson, C. Saint-Marc, and B. Daignan-Fornier. 2002. Screening the yeast "disruptome" for mutants affecting resistance to the immunosuppressive drug, mycophenolic acid. J. Biol. Chem. 277:27036-27044.
17. Gregory, P. D., A. Schmid, M. Zavari, M. Munsterkotter, and W. Horz. 1999. Chromatin remodeling at the PHO8 promoter requires SWI-SNF and SAGA at a step subsequent to activator binding. EMBO J. 18:6407-6414.[CrossRef][Medline]
18. Gutierrez, J. L., M. Chandy, M. J. Carrozza, and J. L. Workman. 2007. Activation domains drive nucleosome eviction by SWI/SNF. EMBO J. 26:730-740.[CrossRef][Medline]
19. Hassan, A. H., K. E. Neely, and J. L. Workman. 2001. Histone acetyltransferase complexes stabilize Swi/Snf binding to promoter nucleosomes. Cell 104:817-827.[CrossRef][Medline]
20. Hirschhorn, J. N., S. A. Brown, C. D. Clark, and F. Winston. 1992. Evidence that SNF2/SWI2 and SNF5 activate transcription in yeast by altering chromatin structure. Genes Dev. 6:2288-2298.
21. Holstege, F. C., E. G. Jennings, J. J. Wyrick, T. I. Lee, C. J. Hengartner, M. R. Green, T. R. Golub, E. S. Lander, and R. A. Young. 1998. Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95:717-728.[CrossRef][Medline]
22. Izban, M. G., and D. S. Luse. 1992. Factor-stimulated RNA polymerase II transcribes at physiological elongation rates on naked DNA but very poorly on chromatin templates. J. Biol. Chem. 267:13647-13655.
23. Izban, M. G., and D. S. Luse. 1991. Transcription on nucleosomal templates by RNA polymerase II in vitro: inhibition of elongation with enhancement of sequence-specific pausing. Genes Dev. 5:683-686.
24. Joshi, A. A., and K. Struhl. 2005. Interaction of the Eaf3 chromodomain with methylated histone H3-K36 mediates preferential histone deacetylation at mRNA coding regions. Mol. Cell 20:971-978.[CrossRef][Medline]
25. Kaplan, C. D., L. Laprade, and F. Winston. 2003. Transcription elongation factors repress transcription initiation from cryptic sites. Science 301:1096-1099.
26. Korber, P., T. Luckenbach, D. Blaschke, and W. Horz. 2004. Evidence for histone eviction in trans upon induction of the yeast PHO5 promoter. Mol. Cell. Biol. 24:10965-10974.
27. Kristjuhan, A., and J. Q. Svejstrup. 2004. Evidence for distinct mechanisms facilitating transcript elongation through chromatin in vivo. EMBO J. 23:4243-4252.[CrossRef][Medline]
28. Kuras, L., and K. Struhl. 1999. Binding of TBP to promoters in vivo is stimulated by activators and requires Pol II holoenzyme. Nature 399:609-612.[CrossRef][Medline]
29. Laurent, B. C., M. A. Treitel, and M. Carlson. 1991. Functional interdependence of the yeast SNF2, SNF5, and SNF6 proteins in transcriptional activation. Proc. Natl. Acad. Sci. USA 88:2687-2691.
30. Lee, C. K., Y. Shibata, B. Rao, B. D. Strahl, and J. D. Lieb. 2004. Evidence for nucleosome depletion at active regulatory regions genome-wide. Nat. Genet. 36:900-905.[CrossRef][Medline]
31. Lomvardas, S., and D. Thanos. 2001. Nucleosome sliding via TBP DNA binding in vivo. Cell 106:685-696.[CrossRef][Medline]
32. Lorch, Y., B. Maier-Davis, and R. D. Kornberg. 2006. Chromatin remodeling by nucleosome disassembly in vitro. Proc. Natl. Acad. Sci. USA 103:3090-3093.
33. Malone, E. A., C. D. Clark, A. Chiang, and F. Winston. 1991. Mutations in the SPT16/CDC68 suppress cis- and trans-acting mutations that affect promoter function in Saccharomyces cerevisiae. Mol. Cell. Biol. 11:5710-5717.
34. Mason, P. B., and K. Struhl. 2005. Distinction and relationship between elongation rate and processivity of RNA polymerase II in vivo. Mol. Cell 17:831-840.[CrossRef][Medline]
35. Mason, P. B., and K. Struhl. 2003. The FACT complex travels with elongating RNA polymerase II and is important for the fidelity of transcriptional initiation in vivo. Mol. Cell. Biol. 23:8323-8333.
36. Matallana, E., L. Franco, and J. E. Perez-Ortin. 1992. Chromatin structure of the yeast SUC2 promoter in regulatory mutants. Mol. Gen. Genet. 231:395-400.[CrossRef][Medline]
37. Mitra, D., E. J. Parnell, J. W. Landon, Y. Yu, and D. J. Stillman. 2006. SWI/SNF binding to the HO promoter requires histone acetylation and stimulates TATA-binding protein recruitment. Mol. Cell. Biol. 26:4095-4110.
38. Moshkin, Y. M., J. A. Armstrong, R. K. Maeda, J. W. Tamkun, P. Verrijzer, J. A. Kennison, and F. Karch. 2002. Histone chaperone ASF1 cooperates with the Brahma chromatin-remodeling machinery. Genes Dev. 16:2621-2626.
39. Narlikar, G. J., H.-Y. Fan, and R. E. Kingston. 2002. Cooperation between complexes that regulate chromatin and transcription. Cell 108:475-487.[CrossRef][Medline]
40. Natarajan, K., B. M. Jackson, H. Zhou, F. Winston, and A. G. Hinnebusch. 1999. Transcriptional activation by Gcn4 involves independent interactions with the Swi/Snf complex and the Srb/mediator. Mol. Cell 4:657-664.[CrossRef][Medline]
41. Neely, K. E., A. H. Hassan, C. E. Brown, L. Howe, and J. L. Workman. 2002. Transcription activator interactions with multiple SWI/SNF subunits. Mol. Cell. Biol. 22:1615-1625.
42. Neely, K. E., A. H. Hassan, A. E. Wallberg, D. J. Steger, B. R. Cairns, A. P. Wright, and J. L. Workman. 1999. Activation domain-mediated targeting of the SWI/SNF complex to promoters stimulates transcription from nucleosome arrays. Mol. Cell 4:649-655.[CrossRef][Medline]
43. Neigeborn, L., K. Rubin, and M. Carlson. 1986. Suppressors of SNF2 mutations restore invertase derepression and cause temperature-sensitive lethality in yeast. Genetics. 112:741-753.
44. Ng, H. H., F. Robert, R. A. Young, and K. Struhl. 2002. Genome-wide location and regulated recruitment of the RSC nucleosome-remodeling complex. Genes Dev. 16:806-819.
45. Ng, H. H., F. Robert, R. A. Young, and K. Struhl. 2003. Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol. Cell 11:709-719.[CrossRef][Medline]
46. Ng, H. H., R. M. Xu, Y. Zhang, and K. Struhl. 2002. Ubiquitination of histone H2B by Rad6 is required for efficient Dot1-mediated methylation of histone H3-lysine 79. J. Biol. Chem. 277:34655-34657.
47. Prochasson, P., K. E. Neely, A. H. Hassan, B. Li, and J. L. Workman. 2003. Targeting activity is required for Swi/Snf function in vivo and is accomplished through two partially redundant activator-interaction domains. Mol. Cell 12:983-990.[CrossRef][Medline]
48. Proft, M., and K. Struhl. 2004. A MAP kinase-mediated stress relief response that precedes and regulates the timing of transcriptional induction. Cell 118:351-361.[CrossRef][Medline]
49. Qiu, H., C. Hu, S. Yoon, K. Natarajan, M. J. Swanson, and A. G. Hinnebusch. 2004. An array of coactivators is required for optimal recruitment of TATA binding protein and RNA polymerase II by promoter-bound Gcn4p. Mol. Cell. Biol. 24:4104-4117.
50. Reinke, H., and W. Horz. 2003. Histones are first hyperacetylated and then lose contact with the activated PHO5 promoter. Mol. Cell 11:1599-1607.[CrossRef][Medline]
51. Schermer, U. J., P. Korber, and W. Horz. 2005. Histones are incorporated in trans during reassembly of the yeast PHO5 promoter. Mol. Cell 19:279-286.[CrossRef][Medline]
52. Schwabish, M. A., and K. Struhl. 2006. Asf1 mediates histone eviction and deposition during elongation by RNA polymerase II. Mol. Cell 22:415-422.[CrossRef][Medline]
53. Schwabish, M. A., and K. Struhl. 2004. Evidence for eviction and rapid deposition of histones upon transcriptional elongation by RNA polymerase II. Mol. Cell. Biol. 24:10111-10117.
54. Smith, C. L., and C. L. Peterson. 2005. ATP-dependent chromatin remodeling. Curr. Top. Dev. Biol. 65:115-148.[Medline]
55. Strasser, K., S. Masuda, P. Mason, J. Pfannstiel, M. Oppizzi, S. Rodriguez-Navarro, A. G. Rondon, A. A. Aguilera, K. Struhl, R. Reed, and E. Hurt. 2002. TREX is a conserved complex coupling transcription with mRNA export. Nature 417:304-307.[CrossRef][Medline]
56. Sudarsanam, P., V. R. Iyer, P. O. Brown, and F. Winston. 2000. Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 97:3364-3369.
57. Sudarsanam, P., and F. Winston. 2000. The Swi/Snf family of nucleosome-remodeling complexes and transcriptional control. Trends Genet. 16:345-351.[CrossRef][Medline]
58. Wilson, C. J., D. M. Chao, A. N. Imbalzano, G. R. Schnitzler, R. E. Kingston, and R. A. Young. 1996. RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling. Cell 84:235-244.[CrossRef][Medline]
59. Workman, J. L. 2006. Nucleosome displacement in transcription. Genes Dev. 20:2009-2017.
60. Yoon, S., H. Qui, M. J. Swanson, and A. G. Hinnebusch. 2003. Recruitment of SWI/SNF by Gcn4p does not require Snf2p or Gcn5p but depends strongly on SWI/SNF integrity, SRB mediator, and SAGA. Mol. Cell. Biol. 23:8829-8845.
61. Yoshinaga, S. K., C. L. Peterson, I. Herskowitz, and K. R. Yamamoto. 1992. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258:1598-1604.
62. Yudkovsky, N., C. Logie, S. Hahn, and C. L. Peterson. 1999. Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators. Genes Dev. 13:2369-2374.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|